Grove Biopharma

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives

Board Members

Investors

Total Funding

$44M

Investors

13 investors across all rounds

DCVC Bio

Deepwork Capital

Eli Lilly

Gradiant

InVivium Capital

+8 more investors

Explore More Data

Detailed analysis for Grove Biopharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Grove Biopharma Leadership & Investors

Grove Biopharma is led by a team of experienced leaders. The company has attracted investment from 13 institutional and strategic investors.

Who Has Invested in Grove Biopharma?

Grove Biopharma has raised $44M from 13 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Grove Biopharma shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.